Hecht Beth - Insider Non-Derivative Transactions at Xeris Biopharma Holdings, Inc. (XERS) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 31, 2024, Hecht Beth's relationship to Xeris Biopharma Holdings, Inc. (XERS) is Officer (See Remarks), and currently has 1,554,968 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other XERS insiders.

Data Source: SEC.
Hecht Beth - Insider Non-Derivative Transactions of XERS Common Stock
Hecht Beth - Insider Non-Derivative Transactions at XERS
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 1, 2024 F -- (Common Stock) 45909 2.46 1380802
Feb 1, 2024 Acquisition -- (Common Stock) 750000 0 1554968
Jan 30, 2024 F -- (Common Stock) 19675 2.66 1426711
Jan 4, 2024 F -- (Common Stock) 33488 2.24 1446386
Feb 1, 2023 Acquisition -- (Common Stock) 350000 0 797758
Feb 1, 2023 F -- (Common Stock) 5784 1.24 1479874
Jan 30, 2023 F -- (Common Stock) 21177 1.26 1485658
Jan 4, 2023 F -- (Common Stock) 33488 1.12 1506835
Feb 1, 2022 F -- (Common Stock) 4448 2.11 1540323
Jan 30, 2022 F -- (Common Stock) 14037 2.11 1544771